Valuation: Medivolve Inc.

Market Cap 233K 166K 149K 138K 125K 15.83M 236K 1.65M 657K 8.28M 624K 610K 26.29M P/E 2022
-0.19x
P/E 2023 -0.02x
Enterprise Value 898K 640K 574K 531K 481K 60.95M 909K 6.35M 2.53M 31.9M 2.4M 2.35M 101M EV / Sales 2022
22,007x
EV / Sales 2023 1,535,308x
Free-Float
94.14%
Yield 2022 *
-
Yield 2023 -
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.05
5 years 0
Extreme 1.0E-6
3
10 years 0
Extreme 1.0E-6
10.35
Manager TitleAgeSince
Investor Relations Contact - -
Date Insider Type Main position Quantity % Market Cap. Importance
04/04/24 Tax

Chief Executive Officer

6,203,788 22.9606%
21/02/24 Option 750,000 2.7758%
21/02/24 Buy 750,000 2.7758%
Change 5-day change 1-year change 3-year change Capi.($)
-99.00%0.00% - - 27
+1.61%+1.46%+26.28%+62.21% 256B
+0.89%+0.09%+7.92%+26.46% 163B
-0.38%+3.75%-18.56%+71.84% 155B
-5.84%-4.67%-57.98%-15.22% 65.3B
+1.06%+3.82%+11.67%+47.18% 52.35B
+1.72%+2.78%-13.92%-7.13% 51.93B
+1.39%-0.85%+9.09%+67.03% 50.75B
+2.25%+2.10%+24.43%+79.38% 50.04B
+1.78%+4.24%+37.85%+101.47% 46.03B
Average -9.29%+1.56%+2.97%+48.13% 89.04B
Weighted average by Cap. +0.88%+1.68%+5.26%+49.99%

Financials

2022 2023
Net sales 37.18 26.49 23.76 21.97 19.9 2.52K 37.62 262.69 104.63 1.32K 99.39 97.3 4.19K 0.69 0.49 0.44 0.41 0.37 46.58 0.69 4.85 1.93 24.38 1.84 1.8 77.38
Net income -18.37M -13.09M -11.74M -10.85M -9.83M -1.25B -18.59M -130M -51.69M -652M -49.1M -48.07M -2.07B -16.46M -11.73M -10.52M -9.73M -8.81M -1.12B -16.66M -116M -46.32M -584M -44M -43.07M -1.86B
Net Debt -2.64M -1.88M -1.69M -1.56M -1.42M -179M -2.68M -18.69M -7.44M -93.92M -7.07M -6.92M -298M 665K 474K 425K 393K 356K 45.12M 673K 4.7M 1.87M 23.61M 1.78M 1.74M 74.96M
Projected Income Statement - Annual - Medivolve Inc.
Logo Medivolve Inc.
Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.
Employees
25
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. MEDVF Stock